Drug Makers Score Big Off of Price Hikes, Sky-High Launch Prices As Americans continue to struggle to afford their prescription drug medications, earnings announcements from brand name drug giants Johnson & Johnson, Roche and Novartis demonstrated that price-gouging American patients continues to be a profit-generator for Big Pharma. All three Big Pharma companies surpassed earnings […]
In case you missed it, a new analysis from the Kaiser Family Foundation (KFF) found Big Pharma hiked the price of 20 of the top 25 Medicare Part D drugs at rates three to nine times the rate of inflation between 2016 and 2017. Top brand name price increases included: 7 percent for Lyrica 3 […]
In yet another example of how Big Pharma attempts to game the system, Bloomberg Government reports that six of the industry’s top brand name drug manufacturers “funneled more than $680 million into hundreds of nonprofits last year, including many now campaigning against federal legislation to tackle the rising cost of medicine.” And while donating to […]
Unjustified Price Increases Cost Patients And Health Plans Billions Big Pharma repeatedly hikes prices on brand name drugs without making any improvements to those medications. That’s the finding of a new analysis conducted by the Institute for Clinical and Economic Review (ICER). The report found that drug companies hiked prices on seven popular drugs in […]
House E&C Health Subcommittee Reiterate Need for Action to Hold Big Pharma Accountable, Deliver Relief for American Patients The U.S. House Energy and Commerce Subcommittee on Health held a hearing Wednesday on the drug pricing package put forward by Speaker Pelosi earlier this week. During the hearing, lawmakers from both sides of the aisle expressed […]
An Unprecedented Opportunity for Washington to Lower Drug Prices Lauren Aronson The Hill Congress was gaveled back into session this month with unprecedented momentum behind legislative efforts to hold Big Pharma accountable and lower prescription drug prices. An array of key factors are aligned that make now the time that lawmakers simply must act to […]
Members of E&C Consumer Protection Subcommittee Call for Bipartisan Action to Hold Brand Name Drug Makers Accountable The U.S. House Energy & Commerce Subcommittee on Consumer Protection & Commerce held a hearing on “Exposing How Pharmaceutical Companies Game The System” on Thursday. During the hearing, lawmakers called out Big Pharma for a number of […]
In case you missed it, a recent article in HealthLeaders details how brand name drug maker Mallinckrodt used a foundation to secretly hike the price of the drug Acthar from $50 to $32,200 over a 13-year period, all while marketing the drug as ‘free’ in an illegal kickback scheme. The company used kickbacks in the […]
Americans Have Negative View of Drug Makers by Two-to-One Margin, Worst of Any Industry And the winner of this year’s most poorly regarded U.S. industry? We’ll give you a hint. It’s not oil and gas, big banks or even the federal government – it’s Big Pharma. A new poll released this morning from Gallup finds […]
Voices From Around the Country Call for Congress to Pass Senate Finance Package Americans across the country are urging Congress to hold Big Pharma accountable and lower prescription drug prices by passing The Prescription Drug Pricing Reduction Act Of 2019. This bipartisan, market-based legislative package marks an important first step towards tackling the crisis of […]